General Information of the Cell Line
Cell Line ID
CL000075
Cell Line Name
EoL-1
Synonyms
EOL-1
EOL1
EoL-1-cell
EoL-1 cell
AML-EOL-1
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0258
Tissue Information
Peripheral blood
Disease
Chronic eosinophilic leukemia, not otherwise specified (NCIt: C4563)
Chronic eosinophilic leukemia (ORDO: Orphanet_168940)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Compound ID Compound Name Compound Formula
CP0016203
Bis-(5-hydroxy-1H-indol-2-yl)-methanone
   Show/Hide
C17H12N2O3
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0029241
(5-Hydroxy-1H-indol-2-yl)-(4-methyl-1H-indol-2-yl)-methanone
   Show/Hide
C18H14N2O2
 1
1
IC50 = 60 nM
   TI
   LI
   LO
   TS
CP0032281
(5-Fluoro-1H-indol-2-yl)-(5-hydroxy-1H-indol-2-yl)-methanone
   Show/Hide
C17H11FN2O2
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0351995
5-hydroxybenzo[b]furan-2-yl-(5-hydroxy-1Hindol-2-yl)methanone
   Show/Hide
C17H11NO4
 1
1
IC50 = 270 nM
   TI
   LI
   LO
   TS
CP0024830
(4-Fluoro-1H-indol-2-yl)-(5-hydroxy-1H-indol-2-yl)-methanone
   Show/Hide
C17H11FN2O2
 1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0291031
(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone
   Show/Hide
C17H11NO2
 1
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
CP0029240
(5-Hydroxy-1H-indol-2-yl)-(6-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H14N2O3
 1
1
IC50 = 530 nM
   TI
   LI
   LO
   TS
CP0010647
(5-Hydroxy-1H-2-indolyl)(1H-2-indolyl)-methanone
   Show/Hide
C17H12N2O2
 1
1
IC50 = 570 nM
   TI
   LI
   LO
   TS
CP0132616
bis(5-amino-1-benzofuran-2-yl)methanone
   Show/Hide
C17H12N2O3
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0021114
(5-Hydroxy-1H-indol-2-yl)-(4-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H14N2O3
 1
1
IC50 = 670 nM
   TI
   LI
   LO
   TS
CP0026540
(4-Methyl-1H-indol-2-yl)-[5-(2-piperidin-1-yl-ethoxy)-1H-indol-2-yl]-methanone
   Show/Hide
C25H27N3O2
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0022413
(5-Hydroxy-1H-indol-2-yl)-(5-methyl-1H-indol-2-yl)-methanone
   Show/Hide
C18H14N2O2
 1
1
IC50 = 740 nM
   TI
   LI
   LO
   TS
CP0018309
(5-Fluoro-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H13FN2O2
 1
1
IC50 = 880 nM
   TI
   LI
   LO
   TS
CP0001023
(6-Methoxy-1H-2-indolyl)(1H-2-indolyl)methanone
   Show/Hide
C18H14N2O2
 1
1
IC50 = 890 nM
   TI
   LI
   LO
   TS
CP0015762
(4-Chloro-1H-indol-2-yl)-(5-hydroxy-1H-indol-2-yl)-methanone
   Show/Hide
C17H11ClN2O2
 1
1
IC50 = 920 nM
   TI
   LI
   LO
   TS
CP0026541
(6-Fluoro-1H-indol-2-yl)-(5-hydroxy-1H-indol-2-yl)-methanone
   Show/Hide
C17H11FN2O2
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0011624
AG1295
   Show/Hide
C16H14N2
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0021115
(5-Hydroxy-1H-indol-2-yl)-(6-methyl-1H-indol-2-yl)-methanone
   Show/Hide
C18H14N2O2
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0020863
(6-Methoxy-1H-indol-2-yl)-[5-(2-piperidin-1-yl-ethoxy)-1H-indol-2-yl]-methanone
   Show/Hide
C25H27N3O3
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0021407
(5-Fluoro-1H-indol-2-yl)-[5-(2-piperidin-1-yl-ethoxy)-1H-indol-2-yl]-methanone
   Show/Hide
C24H24FN3O2
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0337767
[2-(5-acetyloxy-1-benzofuran-2-carbonyl)-1-benzofuran-5-yl] acetate
   Show/Hide
C21H14O7
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0351996
bis(6-hydroxy-1-benzofuran-2-yl)methanone
   Show/Hide
C17H10O5
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0021116
(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone
   Show/Hide
C17H11FN2O
 1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0017087
(5-Fluoro-1H-indol-2-yl)-(4-methyl-1H-indol-2-yl)-methanone
   Show/Hide
C18H13FN2O
 1
1
IC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0029247
(5-methoxy-1H-indol-2-yl)-(4-methyl-1H-indol-2-yl)methanone
   Show/Hide
C19H16N2O2
 1
1
IC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0010180
(5-Methoxy-1H-2-indolyl)(1H-2-indolyl)methanone
   Show/Hide
C18H14N2O2
 1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0017086
(4-Bromo-1H-indol-2-yl)-(5-hydroxy-1H-indol-2-yl)-methanone
   Show/Hide
C17H11BrN2O2
 1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0216885
bis(1-benzofuran-2-yl)methanone
   Show/Hide
C17H10O3
 1
1
IC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0309449
bis(5-hydroxy-1-benzofuran-2-yl)methanone
   Show/Hide
C17H10O5
 1
1
IC50 = 3600 nM
   TI
   LI
   LO
   TS
CP0018310
(1H-indol-2-yl)-(4-methoxy-1H-indol-2-yl)methanone
   Show/Hide
C18H14N2O2
 1
1
IC50 = 4400 nM
   TI
   LI
   LO
   TS
CP0022919
bis(1H-indol-2-yl)methanone
   Show/Hide
C17H12N2O
 1
1
IC50 = 4600 nM
   TI
   LI
   LO
   TS
CP0026269
(5-Hydroxy-1H-indol-2-yl)-(7-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H14N2O3
 1
1
IC50 = 6600 nM
   TI
   LI
   LO
   TS
CP0029239
[5-[2-(dimethylamino)ethoxy]-1H-indol-2-yl]-(6-methoxy-1H-indol-2-yl)methanone
   Show/Hide
C22H23N3O3
 1
1
IC50 = 6700 nM
   TI
   LI
   LO
   TS
CP0029244
(6-Fluoro-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H13FN2O2
 1
1
IC50 = 7600 nM
   TI
   LI
   LO
   TS
CP0032282
(6-Chloro-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H13ClN2O2
 1
1
IC50 = 9400 nM
   TI
   LI
   LO
   TS
CP0026270
(5-Bromo-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H13BrN2O2
 1
1
IC50 = 9900 nM
   TI
   LI
   LO
   TS
CP0017088
(5-Methoxy-1H-indol-2-yl)-(5-methyl-1H-indol-2-yl)-methanone
   Show/Hide
C19H16N2O2
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0021123
(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone
   Show/Hide
C23H16N2O2
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0022414
(5-Benzyloxy-1H-indol-2-yl)-(6-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C25H20N2O3
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0024831
(7-Ethyl-1H-indol-2-yl)-(5-hydroxy-1H-indol-2-yl)-methanone
   Show/Hide
C19H16N2O2
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0029243
(4-Chloro-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H13ClN2O2
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0029245
(4-Fluoro-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H13FN2O2
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0029246
(5-Methoxy-1H-indol-2-yl)-(6-methyl-1H-indol-2-yl)-methanone
   Show/Hide
C19H16N2O2
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0029242
(5-Chloro-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H13ClN2O2
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0062264
bis(4-methoxy-1-benzofuran-2-yl)methanone
   Show/Hide
C19H14O5
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0104544
bis(7-methoxy-1-benzofuran-2-yl)methanone
   Show/Hide
C19H14O5
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0346353
bis(6-methoxy-1-benzofuran-2-yl)methanone
   Show/Hide
C19H14O5
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0529065
bis(5-methoxy-1-benzofuran-2-yl)methanone
   Show/Hide
C19H14O5
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0562616
bis(7-hydroxy-1-benzofuran-2-yl)methanone
   Show/Hide
C17H10O5
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0015763
(5-Benzyloxy-1H-indol-2-yl)-(5-fluoro-1H-indol-2-yl)-methanone
   Show/Hide
C24H17FN2O2
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0021126
(1H-Indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methane
   Show/Hide
C18H16N2O
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0026268
(7-Fluoro-1H-indol-2-yl)-(5-hydroxy-1H-indol-2-yl)-methanone
   Show/Hide
C17H11FN2O2
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0029043
(7-Chloro-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methanone
   Show/Hide
C18H13ClN2O2
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0029248
(5-Fluoro-1H-indol-2-yl)-(5-methoxy-1H-indol-2-yl)-methane
   Show/Hide
C18H15FN2O
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0002607
2-N-[(1R,2S)-2-aminocyclohexyl]-6-N-(3-chlorophenyl)-9-ethylpurine-2,6-diamine
   Show/Hide
C19H24ClN7  1
1
GI50 = 990 nM
   TI
   LI
   LO
   TS
CP0002778
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
   Show/Hide
C29H31N7O  2
1
GI50 < 1 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.1995 nM
   TI
   LI
   LO
   TS
CP0002910
2-N-(4-aminocyclohexyl)-6-N-(3-chlorophenyl)-9-[(4-methoxyphenyl)methyl]purine-2,6-diamine
   Show/Hide
C25H28ClN7O  1
1
GI50 = 530 nM
   TI
   LI
   LO
   TS
CP0007143
CHEMBL4207053
   Show/Hide
C21H28ClN7  1
1
GI50 = 160 nM
   TI
   LI
   LO
   TS
CP0011880
(E)-3-[4-(1-cyclopropylpyrazol-4-yl)pyridin-3-yl]-N-[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]prop-2-enamide
   Show/Hide
C24H23F2N5O  1
1
GI50 = 6.5 nM
   TI
   LI
   LO
   TS
CP0014497
2-N-(4-aminocyclohexyl)-6-N-(3,5-dimethoxyphenyl)-9-hexylpurine-2,6-diamine
   Show/Hide
C25H37N7O2  1
1
GI50 = 380 nM
   TI
   LI
   LO
   TS
CP0039390
(E)-4-(3-(hydroxyamino)-3-oxoprop-1-enyl)-N-(4-methyl-3-(4-(pyridin-3-yl)thiazol-2-ylamino)phenyl)benzamide
   Show/Hide
C25H21N5O3S  1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0151685
N-(2-aminophenyl)-4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]anilino]methyl]benzamide
   Show/Hide
C30H27N7O  1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0173297
3-[3-(benzofuran-2-carbonyl)phenyl]-N-hydroxyacrylamide
   Show/Hide
C18H13NO4  1
1
IC50 = 49 nM
   TI
   LI
   LO
   TS
CP0204863
(E)-N-hydroxy-3-(4-((4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenylamino)methyl)phenyl)acrylamide
   Show/Hide
C26H24N6O2  2
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
2
IC50 = 125.89 nM
   TI
   LI
   LO
   TS
CP0214999
2-N-(2-aminophenyl)-5-N-[4-methyl-3-[(5-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]thiophene-2,5-dicarboxamide
   Show/Hide
C28H23N7O2S  1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0286328
4-N-(2-aminophenyl)-1-N-[4-methyl-3-[(5-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzene-1,4-dicarboxamide
   Show/Hide
C30H25N7O2  1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0294807
(4-(2-aminophenylcarbamoyl)benzylamino)methyl nicotinate
   Show/Hide
C21H20N4O3  1
1
IC50 = 53 nM
   TI
   LI
   LO
   TS
CP0387091
3-[2-[(4-aminocyclohexyl)amino]-6-[2-(morpholin-4-ylmethyl)anilino]purin-9-yl]propan-1-ol
   Show/Hide
C25H36N8O2  1
1
GI50 = 10603 nM
   TI
   LI
   LO
   TS
CP0390610
3-[6-[4-(4-benzylpiperazin-1-yl)anilino]-2-(4-hydroxybutylamino)purin-9-yl]cyclopentan-1-ol
   Show/Hide
C31H40N8O2  1
1
GI50 = 223 nM
   TI
   LI
   LO
   TS
CP0408781
CHEMBL4204373
   Show/Hide
C27H38N8O  1
1
GI50 = 7 nM
   TI
   LI
   LO
   TS
CP0435605
2-N-(4-aminocyclohexyl)-9-cyclopentyl-6-N-[3-(morpholin-4-ylmethyl)phenyl]purine-2,6-diamine
   Show/Hide
C27H38N8O  1
1
GI50 = 12 nM
   TI
   LI
   LO
   TS
CP0435606
CHEMBL4550659
   Show/Hide
C33H43N9O  1
1
GI50 = 11 nM
   TI
   LI
   LO
   TS
CP0438713
2-N-(4-aminocyclohexyl)-9-cyclopentyl-6-N-[6-(furan-3-yl)pyridin-3-yl]purine-2,6-diamine
   Show/Hide
C25H30N8O  1
1
GI50 = 17 nM
   TI
   LI
   LO
   TS
CP0458048
CHEMBL4540307
   Show/Hide
C25H30N8OS  1
1
GI50 = 8 nM
   TI
   LI
   LO
   TS
CP0458049
2-N-(4-aminocyclohexyl)-6-N-[4-(5-bromopyridin-2-yl)oxyphenyl]-9-cyclopentylpurine-2,6-diamine
   Show/Hide
C27H31BrN8O  1
1
GI50 = 122 nM
   TI
   LI
   LO
   TS
CP0468603
2-N-(4-aminocyclohexyl)-9-cyclopentyl-6-N-(4-pyrazol-1-ylphenyl)purine-2,6-diamine
   Show/Hide
C25H31N9  1
1
GI50 = 8 nM
   TI
   LI
   LO
   TS
CP0468604
2-N-(4-aminobutyl)-9-cyclopentyl-6-N-[4-(1,3-thiazol-2-yloxy)phenyl]purine-2,6-diamine
   Show/Hide
C23H28N8OS  1
1
GI50 = 118 nM
   TI
   LI
   LO
   TS
CP0482748
3-[[9-cyclopentyl-6-[4-(1,3-thiazol-2-yloxy)anilino]purin-2-yl]amino]propan-1-ol
   Show/Hide
C22H25N7O2S  1
1
GI50 = 442 nM
   TI
   LI
   LO
   TS
CP0520076
3-[2-(4-hydroxybutylamino)-6-[4-(morpholin-4-ylmethyl)anilino]purin-9-yl]cyclopentan-1-ol
   Show/Hide
C25H35N7O3  1
1
GI50 = 162 nM
   TI
   LI
   LO
   TS
CP0550690
3-[2-[(4-aminocyclohexyl)amino]-6-[4-(4-benzylpiperazin-1-yl)anilino]purin-9-yl]propan-1-ol
   Show/Hide
C31H41N9O  1
1
GI50 = 58 nM
   TI
   LI
   LO
   TS
CP0557894
4-[[9-cyclopentyl-6-[4-(1,3-thiazol-2-yloxy)anilino]purin-2-yl]amino]butan-1-ol
   Show/Hide
C23H27N7O2S  1
1
GI50 = 489 nM
   TI
   LI
   LO
   TS
CP0557895
9-cyclopentyl-2-morpholin-4-yl-N-[4-(1,3-thiazol-2-yloxy)phenyl]purin-6-amine
   Show/Hide
C23H25N7O2S  1
1
GI50 = 347 nM
   TI
   LI
   LO
   TS
CP0570956
2-N-(4-aminobutyl)-9-cyclopentyl-6-N-[3-(morpholin-4-ylmethyl)phenyl]purine-2,6-diamine
   Show/Hide
C25H36N8O  1
1
GI50 = 61 nM
   TI
   LI
   LO
   TS
CP0570957
3-[2-[(4-aminocyclohexyl)amino]-6-[3-(morpholin-4-ylmethyl)anilino]purin-9-yl]cyclopentan-1-ol
   Show/Hide
C27H38N8O2  1
1
GI50 = 9 nM
   TI
   LI
   LO
   TS
CP0570958
3-[2-(4-aminobutylamino)-6-[4-(4-benzylpiperazin-1-yl)anilino]purin-9-yl]cyclopentan-1-ol
   Show/Hide
C31H41N9O  1
1
GI50 = 46 nM
   TI
   LI
   LO
   TS
CP0576087
2-N-(4-aminocyclohexyl)-9-cyclopentyl-6-N-[4-(1,2,4-triazol-4-yl)phenyl]purine-2,6-diamine
   Show/Hide
C24H30N10  1
1
GI50 = 5 nM
   TI
   LI
   LO
   TS
CP0576088
CHEMBL4530087
   Show/Hide
C28H34N8O  1
1
GI50 = 14 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Peripheral blood)
Cell Line Name Organism Disease
SET-2 Homo sapiens (Human) Adult acute megakaryoblastic leukemia
Mono-Mac-6 Homo sapiens (Human) Adult acute monocytic leukemia
HL-60 Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-13 Homo sapiens (Human) Adult acute myeloid leukemia
OCI-AML-2 Homo sapiens (Human) Adult acute myeloid leukemia
HL-60/ADR Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-14 Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MDR Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MRP Homo sapiens (Human) Adult acute myeloid leukemia
NALM-6 Homo sapiens (Human) Adult B acute lymphoblastic leukemia
MOLT-4 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
MOLT-4/CCR5 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
Karpas-299 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
M-07e Homo sapiens (Human) Childhood acute megakaryoblastic leukemia
THP-1 Homo sapiens (Human) Childhood acute monocytic leukemia
MV4-11 Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual KO-STING Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Blue ISG Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-ASC-GFP Homo sapiens (Human) Childhood acute monocytic leukemia
PMNL Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Xblue Homo sapiens (Human) Childhood acute monocytic leukemia
SEM Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
SEMK2 Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Reh Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
Jurkat E6.1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-CEM Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF/VCR1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB100 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB500 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-SS Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
HPB-ALL Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-SB Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-T4 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
J-Lat 10.6 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
12D7-MDR1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
MDR CCRF vcr1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
FGS7 Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CII Homo sapiens (Human) Chronic lymphocytic leukemia
Ku812 Homo sapiens (Human) Chronic myelogenous leukemia, BCR-ABL1 positive
Ri-1 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
Daudi Homo sapiens (Human) EBV-related Burkitt lymphoma
HEL Homo sapiens (Human) Erythroleukemia
UKE-1 Homo sapiens (Human) Essential thrombocythemia
L-1236 Homo sapiens (Human) Hodgkin lymphoma
Granta-519 Homo sapiens (Human) Mantle cell lymphoma
JeKo-1 Homo sapiens (Human) Mantle cell lymphoma
Mino Homo sapiens (Human) Mantle cell lymphoma
HMC-1 Homo sapiens (Human) Mast cell leukemia
NK-92 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
NK Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
KHYG-1 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
RPMI-8226 Homo sapiens (Human) Plasma cell myeloma
OPM-2 Homo sapiens (Human) Plasma cell myeloma
U266B1 Homo sapiens (Human) Plasma cell myeloma
KMS-18 Homo sapiens (Human) Plasma cell myeloma
MM1.S Homo sapiens (Human) Plasma cell myeloma
MM1.R Homo sapiens (Human) Plasma cell myeloma
OPM-1 Homo sapiens (Human) Plasma cell myeloma
RPMI-8226/Dox40 Homo sapiens (Human) Plasma cell myeloma
HuT 78 Homo sapiens (Human) Sezary syndrome
H9 Homo sapiens (Human) Sezary syndrome
CREM010i-SS9-1 Homo sapiens (Human) Sickle cell disease
RBL-1 Rattus norvegicus (Rat) Rat leukemia
RBL-2H3 Rattus norvegicus (Rat) Rat leukemia
LCL Orang Asli K28 Homo sapiens (Human) -
JY Homo sapiens (Human) -
C.M.L. Homo sapiens (Human) -
BON Homo sapiens (Human) -
PBMC iPSC #1 Homo sapiens (Human) -
LCL 721 Homo sapiens (Human) -